Belge G - Search Results

1

Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.

Belge G, Dumlupinar C, Nestler T, Klemke M, Törzsök P, Trenti E, Pichler R, Loidl W, Che Y, Hiester A, Matthies C, Pichler M, Paffenholz P, Kluth L, Wenzel M, Sommer J, Heinzelbecker J, Schriefer P, Winter A, Zengerling F, Kramer MW, Lengert M, Frey J, Heidenreich A, Wülfing C, Radtke A, Dieckmann KP. Belge G, et al. Clin Cancer Res. 2024 Jan 17;30(2):404-412. doi: 10.1158/1078-0432.CCR-23-0730. Clin Cancer Res. 2024. PMID: 37967143 Free PMC article.

2

An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591.

Vockerodt M, Belge G, Kube D, Irsch J, Siebert R, Tesch H, Diehl V, Wolf J, Bullerdiek J, Staratschek-Jox A. Vockerodt M, et al. Among authors: belge g. Br J Haematol. 2002 Dec;119(3):640-6. doi: 10.1046/j.1365-2141.2002.03894.x. Br J Haematol. 2002. PMID: 12437638 Free article.

3

Deletions of the short arm of chromosome 2 characterize a new cytogenetic subgroup of benign thyroid tumors.

Belge G, Bruckmann S, Thode B, Bartnitzke S, Bullerdiek J. Belge G, et al. Genes Chromosomes Cancer. 1996 Jun;16(2):149-51. doi: 10.1002/(SICI)1098-2264(199606)16:2<149::AID-GCC10>3.0.CO;2-H. Genes Chromosomes Cancer. 1996. PMID: 8818663

4

Cytogenetic biclonality corresponding to multiphasic differentiation in an atypical thyroid adenoma.

Belge G, Thode B, Bartnitzke S, Bullerdiek J. Belge G, et al. Cancer Genet Cytogenet. 1994 Nov;78(1):102-4. doi: 10.1016/0165-4608(94)90055-8. Cancer Genet Cytogenet. 1994. PMID: 7987796

5

Decrease in thyroid adenoma associated (THADA) expression is a marker of dedifferentiation of thyroid tissue.

Kloth L, Belge G, Burchardt K, Loeschke S, Wosniok W, Fu X, Nimzyk R, Mohamed SA, Drieschner N, Rippe V, Bullerdiek J. Kloth L, et al. Among authors: belge g. BMC Clin Pathol. 2011 Nov 4;11:13. doi: 10.1186/1472-6890-11-13. BMC Clin Pathol. 2011. PMID: 22050638 Free PMC article.

6

[Genetic studies of differential fatty tissue tumor diagnosis].

Belge G, Caselitz J, Bonk U, Bartnitzke S, Bullerdiek J. Belge G, et al. Pathologe. 1997 Mar;18(2):160-6. doi: 10.1007/s002920050206. Pathologe. 1997. PMID: 9244875 German.

7

FISH analyses of a newly established thyroid tumor cell line showing a t(1;19)(p35 or p36.1;q13) reveal that the breakpoint lies between 19q13.3-13.4 and 19q13.4.

Belge G, Garcia E, de Jong P, Bartnitzke S, Bullerdiek J. Belge G, et al. Cytogenet Cell Genet. 1995;69(3-4):220-2. doi: 10.1159/000133968. Cytogenet Cell Genet. 1995. PMID: 7698017

8

Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature.

Bol S, Belge G, Thode B, Bartnitzke S, Bullerdiek J. Bol S, et al. Among authors: belge g. Cancer Genet Cytogenet. 1999 Oct 1;114(1):75-7. doi: 10.1016/s0165-4608(99)00028-x. Cancer Genet Cytogenet. 1999. PMID: 10526540

9

Comparison of human corneal cell cultures in cytotoxicity testing.

Zorn-Kruppa M, Tykhonova S, Belge G, Diehl HA, Engelke M. Zorn-Kruppa M, et al. Among authors: belge g. ALTEX. 2004;21(3):129-34. ALTEX. 2004. PMID: 15329776 Free article.

10

A closer look at Warthin tumors and the t(11;19).

Fehr A, Röser K, Belge G, Löning T, Bullerdiek J. Fehr A, et al. Among authors: belge g. Cancer Genet Cytogenet. 2008 Jan 15;180(2):135-9. doi: 10.1016/j.cancergencyto.2007.10.007. Cancer Genet Cytogenet. 2008. PMID: 18206539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page